Correlation analysis of SNRPD2 and SF3A3 expression against the expression of the 789 NJs across all glioma subtypes supported our hypothesis that decreased SNRPD2 and SF3A3 expression levels may contribute to greater NJ expression (Fig. 3k). This evidence concerns the gene SF3A3 and central nervous system cancer.